Eli Lilly and Company and Purdue University announced a significant expansion of their long-standing alliance, with Lilly's planned investment of up to $250 million in the collaboration over the next ...

Eli Lilly has followed Novo Nordisk in announcing ... with investment projects ongoing in North Carolina and Indiana in the US. The new facility in Germany is preparing for the future, however ...

Commerce officials approved an incentives package worth up to $13.1 million for the company, which plans to build a $700 million plant in the Wake County town. It's the latest drugmaker to target the ...

The executive order instructs the FDA to expedite the approval process for domestic pharmaceutical manufacturing facilities.

The drugmaker has been making noises for some time that the UK is in danger of losing its standing as a good place for life sciences companies to invest ... AbbVie and Eli Lilly – to exit ...

Swiss pharmaceutical giant Roche announced today that it plans to invest 2.04 billion yuan (about $283M) in building a new ...

The head of drugmaker Eli Lilly, which sells the popular weight-loss drug Zepbound, urged the Trump administration to ease up on its tariff rollout because it could hurt Lilly’s business and the ...

Eli Lilly & Co.’s stock soared 14% Thursday, to put it on track for its biggest one-day gain in about 25 years, after the drugmaker reported positive results from a late-stage trial of a GLP-1 ...

Eli Lilly and Company (NYSE: LLY) today announced detailed results from SURMOUNT-5, a Phase 3b open-label clinical trial, evaluating the safety and efficacy of Zepbound (tirzepatide), a dual GIP ...

and Chugai Pharmaceutical Co., Ltd. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.